Skip to main content
. 2023 Oct 6;299(11):105328. doi: 10.1016/j.jbc.2023.105328

Table 4.

Assessment of tepotinib affinity to MET in cell lysates by fluorescence cross correlation spectroscopy

MET protein variants Tepotinib
Ki (nM)
MET (1028–1390)-EGFP 1.3 ± 0.1
MET (1028–1390) [Y1235D]-EGFP 49 ± 4.9
MET (1028–1390) [Y1234 E/Y1235 E]-EGFP 66
MET (full-length)-EGFP 7.6 ± 1.9
MET (full-length) [Y1235D]-EGFP 75.6 ± 8.1